M

Matinas BioPharma Holdings
D

MTNB

0.18510
USD
-0.06
(-23.26%)
Post Trading·0.17620USD-0.00890(-4.81%)
حجم التداول
0
الربح لكل سهم
-2
العائد الربحي
-
P/E
-0
حجم السوق
2,719,637
أصول ذات صلة المقالات
المزيد

العنوان: Matinas Biopharma Holdings Inc

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.